Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: High frequency of a 30-bp deletion

Human Pathology

Volumn 28, Issue 12, 1997, Pages 1408-1414

  Hayashi, Kazuhiko ^b   Chen, Wen Gang ^b   Chen, Yuan Yuan ^b   Bacchi, Maura M ^b   Bacchi, Carlos E ^b   Alvarenga, Marcelo ^b   Abreu, Eliane S ^b   Chang, Karen L ^b   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

Epstein Barr virus (EBV); Hodgkin's disease; Latent membrane protein 1 gene deletion; Typing of EBV

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LYMPHOID HYPERPLASIA; REED STERNBERG CELL; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS TYPING;

EID: 0031453271     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90231-8     Document Type: Article

References (39)

1. Rickinson AB, Kieff E: Epstein-Barr Virus, in Fields BN, Knipe DM, Howley PM, et al (eds): Fields Virology (ed 3). Philadelphia, PA, Lippincott-Raven, 1996, pp 2397-2461
2. Weiss LM, Chang KL: Association of the Epstein-Barr virus with hematolymphoid neoplasia. Adv Anat Pathol 3:1-15, 1996
3. Weiss LM, Strickler JG, Warnke RA, et al: Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 129:86-91, 1987
4. Weiss LM, Movahed LA, Warnke RA, et al: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502-506, 1989
5. Uhara H, Sato Y, Mukai K, et al: Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization. Jpn J Cancer Res 81:272-278, 1990
6. Weiss LM, Chen Y-Y, Liu X-F, et al: Epstein-Barr virus and Hodgkin's disease: A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259-1265, 1991
7. Herbst H, Dallenbach F, Hummel M, et al: Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A 88:4766-4770, 1991
8. Grasser FA, Murray PG, Kremmer E, et al: Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84:3792-3798, 1994
9. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840, 1985
10. Kaye KM, Izumi KM, Kieff E: Epstein-Barr virus latent membrane proteinl is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci U S A 90:9150-9154, 1993
11. Henderson S, Rowe M, Gregory C, et al: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein I protects infected B cells from programmed cell death. Cell 65:1107-1115, 1991
12. Mosialos G, Birkenbach M, Yalamanchili R, et al: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399, 1995
13. Chen M-L, Tsai C-N, Liang C-L, et al: Cloning and characterization of the latent membrane protein (LMP) of a specific EpsteinBarr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140/1992
14. Hu L-F, Chen F, Zheng X, et al: Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575-1583, 1993
15. Hu L-F, Zavarovsky ER, Chen F, et al: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a. Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409, 1991
16. Chang Y-S, Su I-J, Chung P-J, et al: Detection of an EpsteinBarr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 62:673-677, 1995
17. Knecht H, Bachmann E, Brousset P, et al: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937-2942, 1993
18. Sandvej K, Peh S-C, Andresen BS, et al: Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053-4060, 1994
19. Santon A, Manzanal AI, Campo E, et al: Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol Mol Pathol 48:M184-M187, 1995
20. Knecht H, Bachmann E, Brousset P, et al: Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523-528, 1995
21. Vasef MA, Kamel OW, Chen Y-Y, et al: Detection of EpsteinBarr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 147:1408-1415, 1995
22. Chen W-G, Chen Y-Y, Bacchi MM, et al: Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: Type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 148:17-23, 1996
23. Knecht H, Raphaël M, McQuain C, et al: Deletion variants within the NF-κB activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 87:876-881, 1996
24. Kingma DW, Weiss WB, Jaffe ES, et al: Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242-251, 1996
25. Smir BN, Hauke RJ, Bierman PJ, et al: Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Lab Invest 75:575-588, 1996
26. Khanim F, Yao Q-Y, Niedobitek G, et al: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491-3501, 1996
27. Lin J-C, Lin S-C, De BK, et al: Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): Predominance of type A virus associated with Hodgkin's disease. Blood 81:3372-3381, 1993
28. Gledhill S, Gallagher A, Jones DB, et al: Viral involvement in Hodgkin's disease: Detection of clonal type A Epstein-Barr virus in tumour samples. Br J Cancer 64:227-232, 1991
29. Lukes RJ: Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. Cancer Res 31:1755-1767, 1971
30. Sheibani K, Tubbs RR: Enzyme immunohistochemistry: Technical aspects. Semin Diagn Pathol 1:235-250, 1984
31. Gown AM, deWever N, Battifora H: Microwave-based antigenie unmasking: A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1:256-266, 1984
32. Khan G, Coates PJ, Kangro HO, et al: Epstein Barr virus (EBV) encoded small RNAs: Targets for detection by in situ hybridization with oligonucleotide probes. J Clin Pathol 45:616-620, 1992
33. Weiss LM, Movahed LA, Chen Y-Y, et al: Detection of immunoglobulin light-chain mRNA in lymphoid tissues using a practical in situ hybridization method. Am J Pathol 137:979-988, 1990
34. Chang KL, Chen Y-Y, Shibata D, et al: In situ hybridization methodology for the detection of EBV EBER-1 RNA in paraffin-embedded tissues, as applied to normal and neoplastic tissues. Diagn Mol Pathol 1:246-255, 1992
35. Weiss LM, Chen Y-Y: Effects of different fixatives on detection of nucleic acids from paraffin-embedded tissues by in situ hybridization using oligonucleotide probes. J Histochem Cytochem 39:1237-1242, 1991
36. Moorthy RK, Thorley-Lawson DA: All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of Rat-1 fibroblasts. J Virol 67:1638-1646, 1993
37. Wang D, Licbowitz D, Wang F, et al: Epstcin-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J Virol 62:4173-4184, 1988
38. Trivedi P, Hu LF, Chen F, et al: Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 30A:84-88, 1994
39. Gratama JW, Ernberg I: Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 67:197-255, 1995